Campbell & CO Investment Adviser LLC Tandem Diabetes Care Inc Transaction History

Campbell & CO Investment Adviser LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$14.28 - $31.03 $174,987 - $380,241	12,254 New	12,254 $362,000
Q4 2022 Feb 14, 2023	BUY	$35.49 - $56.15 $163,857 - $259,244	4,617 New	4,617 $207,000
Q2 2022 Aug 09, 2022	BUY	$53.22 - $123.09 $746,516 - $1.73 Million	14,027 Added 388.45%	17,638 $1.04 Million
Q1 2022 May 09, 2022	BUY	$101.89 - $150.09 $367,924 - $541,974	3,611 New	3,611 $420,000
Q3 2021 Nov 10, 2021	SELL	$93.51 - $129.4 $289,881 - $401,140	-3,100 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$77.0 - $100.19 $238,700 - $310,589	3,100 New	3,100 $302,000
Q1 2020 Apr 29, 2020	SELL	$47.37 - $90.04 $311,599 - $592,283	-6,578 Closed	0 $0
Q4 2019 Jan 23, 2020	BUY	$53.13 - $71.19 $349,489 - $468,287	6,578 New	6,578 $392,000

352

73M

3.36M

229K

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $2.38B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.